ALNY
Alnylam Pharmaceuticals, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders +11.8% ·
aandelenstroom -4.1% ·
netto nieuwe posities +10.5%
· formule
Fragmentatie van eigendom: meer houders, kleiner totaalbelang
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q1 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q3 2026 | 5 | 0 | 220.72K | $53.70M | n/a | n/a |
| Q2 2026 | 162 | +3 | 107.60M | $32.37B | +7 | −3 |
| Q1 2026 | 161 | -2 | 108.78M | $35.89B | +4 | −7 |
| Q4 2025 | 162 | -2 | 118.83M | $47.26B | +1 | −2 |
| Q3 2025 | 24 | +1 | 85.59M | $39.02B | +2 | −2 |
| Q2 2025 | 21 | -1 | 76.99M | $25.10B | n/a | −1 |
| Q1 2025 | 19 | +2 | 40.24M | $10.86B | +3 | −1 |
| Q4 2024 | 17 | 0 | 41.95M | $9.87B | n/a | n/a |
| Q3 2024 | 16 | +1 | 39.28M | $10.80B | +2 | −1 |
| Q2 2024 | 15 | n/a | 40.30M | $9.79B | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Capital World Investors ✦ | 16.75M | +0.9% | $4.52B | 0.7% | ▲ Add | 4 | SEC ↗ |
| 2 | Baillie Gifford ✦ | 3.66M | -9.5% | $987.63M | 0.9% | ▼ Trim | 4 | SEC ↗ ×4 |
| 3 | T. Rowe Price ✦ | 3.51M | +5.6% | $946.47M | 0.1% | ▲ Add | 4 | SEC ↗ ×2 |
| 4 | State Street Global Advisors ✦ (passief) | 3.37M | -1.6% | $909.04M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | Dodge & Cox ✦ | 3.35M | -5.3% | $905.04M | 0.5% | ▼ Trim | 4 | SEC ↗ |
| 6 | Wellington Management ✦ | 2.61M | -37.8% | $705.02M | 0.1% | ▼ Trim | 4 | SEC ↗ ×8 |
| 7 | Geode Capital Management ✦ (passief) | 2.32M | +5.3% | $625.82M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 8 | Norges Bank ✦ (passief) | 2.14M | -13.0% | $576.77M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 828.34K | +1.8% | $217.03M | 0.2% | ▲ Add | 4 | SEC ↗ ×7 |
| 10 | Point72 Asset Management ✦ | 300.63K | Nieuw | $81.18M | 0.2% | New | 1 | SEC ↗ |
| 11 | D. E. Shaw & Co. ✦ | 289.86K | -20.2% | $78.27M | 0.1% | ▼ Trim | 4 | SEC ↗ ×2 |
| 12 | Millennium Management ✦ | 287.34K | -13.8% | $77.59M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 13 | Adage Capital Partners ✦ | 282.18K | +203.2% | $76.20M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 14 | Marshall Wace ✦ | 268.93K | -29.0% | $72.62M | 0.1% | ▼ Trim | 3 | SEC ↗ ×3 |
| 15 | Two Sigma Investments ✦ | 197.41K | +84.3% | $53.31M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 16 | Soros Fund Management ✦ | 60.00K | Nieuw | $16.20M | 0.4% | New | 1 | SEC ↗ |
| 17 | Gotham Asset Management ✦ | 14.52K | +32.9% | $3.92M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 18 | Citadel Advisors ✦ | 4.24K | -93.5% | $1.14M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 19 | Arrowstreet Capital ✦ | 4.05K | Nieuw | $1.09M | 0.0% | New | 1 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Point72 Asset Management | $81.18M | 0.2% |
| Soros Fund Management | $16.20M | 0.4% |
| Arrowstreet Capital | $1.09M | 0.0% |
Verlaten
| Bridgewater Associates | $1.52M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 781 houders, 122.25M aandelen, $37.95B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer · 1.76K aand · $398,855
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie